Artivion, known by its NYSE ticker symbol AORT, recently revealed it has secured a humanitarian device exemption (HDE) from the FDA for its innovative AMDS Hybrid Prosthesis. Based in Atlanta, the company highlighted that the AMDS is pioneering as the […]
Terumo Health Outcomes, in alliance with Medis Medical Imaging, has unveiled a strategic collaboration focused on advancing cardiovascular care across the United States. The initiative aims to integrate Terumo’s innovative ePRISM clinical decision support system alongside Medis’ QFR technology, a
Terumo and Medis Announce Collaborative Initiative to Advance Cardiovascular Treatment Read More »
Second Heart Assist recently announced the successful conclusion of the third planned evaluation phase for its innovative mechanical circulatory support device. Designed as a catheter-based, minimally invasive tool, the Whisper system functions with a stent cage containing a motorized impeller
Completion of Mechanical Circulatory Support Study by Second Heart Assist Read More »
Microbot Medical (Nasdaq: MBOT) disclosed today its filing of an FDA 510(k) premarket notification for the Liberty surgical robot. This unique device is tailored for use in fields such as neurovascular, cardiovascular, and peripheral vascular surgery. The Liberty system is
Microbot Medical Seeks FDA Approval for Liberty Surgical Robot Read More »
Bespak, an inhalation contract development and manufacturing organization (CDMO), and OzUK, a contract research organization (CRO) focusing on pressurized Metered Dose Inhaler (pMDI) advancement, have announced new enhancements to bolster their joint service offerings in early-phase product feasibility and development.
Roche revealed the latest findings from its pioneering CD20xCD3 T-cell-engaging bispecific antibody program at the 66th Annual Meeting and Exposition of the American Society of Hematology (ASH), held from December 7-10, 2024. More than 20 abstracts featuring bispecific antibodies were
Roche Unveils Latest Findings on Fixed-duration Columvi and Lunsumio at ASH 2024 Read More »
GSK plc revealed that the United States Food and Drug Administration (FDA) has begun the review process for data derived from the MATINEE study to potentially approve Nucala (mepolizumab) as an add-on maintenance therapy targeted at patients with eosinophilic chronic
GSK’s Nucala Gains Favorable Review Position from FDA for COPD Treatment Read More »
The Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME), a dynamic association with over 300 members throughout India, is preparing to convene its eagerly awaited 5th Annual Conclave in Mumbai on December 14, 2024. This event marks a noteworthy
Pharma Export Empowerment: FPME Conclave 2024 Scheduled for December 14 in Mumbai Read More »
In recent developments, patient advocacy groups and organizations focused on rare diseases have urged the national authorities to exercise their rights to make expensive patented medicines for rare conditions more accessible and affordable within the Indian market. These groups emphasize
Urgent Measures Required for Affordability of Rare Disease Medications Read More »
The pharmaceutical sector experienced a significant increase in Foreign Direct Investment (FDI) equity inflow during the first half of the 2024-25 fiscal year, reversing a previous year’s 48% decline. From April to September 2024, the sector witnessed a dramatic increase
Pharma Sector Sees $520 Million Surge in FDI Equity Inflow for First Half of FY25 Read More »